19th October 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Baxter to establish Global Pharmaceutical R&D center in Ahmedabad

Baxter pharmaceuticals India announced the innaugration of state-of-the-art R&D centre in Ahmedabad, Gujarat. The area of the facility is 20,500-square-foot and it will be able to propel the innovation in the generic and differentiated injectable pharmaceuticals space.

Alembic Pharma receives form 483 with 4 observations from USFDA

The firm informed in a regulatory filing that USFDA had conducted an inspection at the company’s Panelav oncology injectable formulation facility in Gujarat from 4th to 14th October, 2022 and has issued a Form 483 with four procedural observations after the inspection.

ED brings Chandigarh-based pharma firm's ₹185 crore worth of assets under PMLA

Enforcement Directorate stated that after the provisional order was issued under the PMLA (Prevention of Money Laundering Act), it has attached assets worth more than ₹185 crore of Chandigarh-based Surya Pharmaceuticals, in connection with a case of alleged bank loan fraud.

J&J beats third quarter sales estimates backed by strong demand of pharmaceuticals

Johnson & Johnson announced the jump of their sales over the estimates given by the analysts’ for third-quarter sales. It became possible because of the two most in-demand drugs namely Cancer drug Darzalex and Crohn’s disease drug Stelara.

All company board directors liable for production of substandard drugs

The board of directors of Sunrise International Labs filed a petition to the Madras High Court to exempt them from any proceedings as they were not involved in the day-to-day working of the company to which the High Court responded by saying that all directors are liable in the present case.

India going beyond health insurance, ensuring health assurance: PM Modi

On 17th October, PM Narendra Modi kickstarted the distribution of PMJAY-MA Yojna Ayushman cards in Gujarat with the help of video conferencing and mentioned that India is going beyond health insurance to ensure health assurance. Additionally, he also mentioned that this program aims for health for all.

Romania-based Pharma group Terapia takes over Uractiv brand

Romanian Pharma group Terapia, Part of Sun Pharma group has decided to take over the Uractiv brand from local companies Fiterman Pharma. The assets brought by Terapia mainly comprises of food supplements products used for urological care and maintaining the health of the urinary tract.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?